Imipenem/Cilastatin-XNW4107 Versus Imipenem/Cilastatin/Relebactam for Treatment of Participants With Bacterial Pneumonia (XNW4107-302, REITAB-2)

NCT05204563 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

450

Enrollment

INDUSTRY

Sponsor class

Conditions

Hospital Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia

Interventions

DRUG: Combination of Imipenem/Cilastatin and XNW4107
DRUG: Imipenem/Cilastatin/Relebactam

Sponsor

Evopoint Biosciences Inc.